Skip to main content
Premium Trial:

Request an Annual Quote

Baylor Genetics Epilepsy Panel, STAT Epilepsy Panel

Baylor Genetics has launched the Epilepsy Panel and STAT Epilepsy Panel. The next-generation sequencing-based Epilepsy Panel analyzes 397 genes that are associated with epilepsy, such as Angelman syndrome, Rett syndrome, SCN1A-related epilepsies, CDKL5 deficiency disorder, Charcot-Marie-Tooth disease, and developmental and epileptic encephalopathies. The STAT Epilepsy Panel is intended for use with patients with new onset of disease or a change in seizure frequency or character, Baylor Genetics said, adding that the turnaround time for the test is 10 days.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.